Skip to content
TechSphere Blog

Zimbabwe Declines ‘Lopsided’ American Healthcare Assistance Deal Due to Data Fears

Health funding illustration
The offered American financial assistance was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has rejected a substantial American healthcare agreement valued at $367m (£272m) over five years over Washington's insistence on confidential information.

This rejection was revealed after a government memo dated December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "lopsided".

An official spokesperson has since explained that the United States was demanding access to biological samples for scientific study and commercial purposes while was unwilling to guarantee the benefits from future medical innovations.

"We are forced to start the difficult and regrettable process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the United States had provided more than $1.9bn as health assistance to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has urged further negotiations to secure a deal acceptable to all parties so the country's critical HIV treatment initiative can proceed.

Wider Context

This rejection comes after a comparable case in Kenya, where a high court blocked a related deal with the US after concerns were filed about the security of Kenyans' health data.

After returning to office last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.

The agency had administered aid for the US government, but Trump stated its spending was "wasteful" and his government was pursuing government-to-government agreements to enhance openness and responsibility.

According to reports, Sixteen African countries have to date agreed to these new agreements, representing more than $18.3bn of fresh investment.

Specifics of the Declined Deal

The money for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment through American-funded programmes," the Ambassador added.

However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".

"Zimbabwe was being asked to share its genetic material and health information indefinitely, with no corresponding guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," his statement read.

"Effectively, our nation would provide the raw materials for medical research without any assurance that the resulting innovations would be available to our population should a new disease outbreak emerge."

Sovereignty and International Frameworks

Mangwana further noted that the American exit from the global health body and its push of bilateral deals were undermining systems previously established via the global health agency.

Mangwana cited its Pathogen Access and Benefit Sharing framework created to deal with potential pandemics.

"This system is intended to guarantee that when a country provides its data, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to develop them."

Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," he added.

"We are open to further dialogue with our American counterparts on how subsequent collaboration could be arranged in a way that respects the independence and dignity of each country."

Health Experts Response

A leading public health body said it recognised the official position, but recommended that negotiations must proceed considering a large portion of the nation's HIV programmes were funded by external financing.

"Where technical issues exist, such as those involving data governance or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," it said.

The situation emphasises the complex tensions between receiving crucial international aid and safeguarding local interests in an increasingly data-driven world.

About the author

Linda Sellers

A software engineer and tech writer passionate about AI ethics and open-source projects, with over a decade of industry experience.

TechSphere Blog

Type to search articles.